Incidence of dementia among individuals 70 years and older in Norway: A HUNT study
BackgroundWith increasing population longevity, Alzheimer's disease and dementia have become a health priority, and high-quality incidence estimates are needed.ObjectiveTo provide reliable and precise incidence estimates of dementia applying a population-based sample of individuals aged 70+.MethodsA longitudinal cohort design was used, with baseline assessment in the Norwegian HUNT4 70+ study (2017-19) and at follow-up four years later (2021-23). Age-specific dementia incidence rates, standardized for the Norwegian population, were calculated as the number of new dementia cases per 1000 person-years assuming onset midway between study waves with inverse probability weights based on baseline factors associated with non-participation or death.ResultsAmong 5229 dementia-free individuals at baseline, 749 developed dementia over a 4.2-year period, resulting in a cumulative incidence proportion of 14.3%. At follow-up, 33.8% of new dementia cases showed no baseline cognitive impairment, while the rest had mild cognitive impairment (MCI). Of those with baseline MCI, 25.5% reverted to normal cognition, 48.2% remained MCI, and 26.2% developed dementia. The dementia incidence per 1000 person-years, was 43.9 (95% confidence interval (CI) 40.8, 47.1) (weighted for non-response and standardized to the dementia-free Norwegian population).ConclusionsOur study found higher dementia incidence rates in the 70+ population than hospital records indicate. Most individuals had preceding MCI, with similar numbers reverting to normal cognition as developing dementia. The projected incident dementia cases suggest a near doubling between 2023 and 2050, significantly impacting families and healthcare planning, including early detection and interventions.
Authors
- Linda Gjøra (ORCID: https://orcid.org/0000-0003-4333-9322)
- Geir Selbæk (ORCID: https://orcid.org/0000-0001-6511-8219)
- Grete Kjelvik
- Marte Kvello-Alme
- Stina Aam (ORCID: https://orcid.org/0000-0002-9116-6991)
- Eivind Aakhus
- Karin Persson (ORCID: https://orcid.org/0000-0001-6198-7804)
- Anne Brækhus
- Knut Engedal (ORCID: https://orcid.org/0000-0001-5304-2018)
- Håvard Kjesbu Skjellegrind (ORCID: https://orcid.org/0000-0003-3067-0016)
- Inger Molvik (ORCID: https://orcid.org/0009-0008-1544-3927)
- Sverre Bergh (ORCID: https://orcid.org/0000-0001-9593-2967)
- Anne Marie Mork Rokstad (ORCID: https://orcid.org/0000-0002-3713-1229)
- Bjørn Heine Strand (ORCID: https://orcid.org/0000-0003-4385-8886)
- Fiona E Matthews
- Gill Livingston
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- Molde University College (NO)
- University of Oslo (NO)
- University of Hull (GB)
- Norwegian University of Science and Technology (NO)
- Innlandet Hospital Trust (NO)
- Levanger Hospital (NO)
- Sykehuset i Vestfold (NO)
- St Olav's University Hospital (NO)
- St Pancras Hospital (GB)
- The London College (GB)
- University College London (GB)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1177/13872877251371242
- Citations
- 2
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 2.94